NCT00055822View on ClinicalTrials.gov

Combination Chemotherapy and Oblimersen in Treating Patients With Advanced Colorectal Cancer

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

October 31, 2002

Primary Completion Date

October 31, 2004

Study Completion Date

October 31, 2004

Conditions
Colorectal Cancer
Interventions
BIOLOGICAL

oblimersen sodium

DRUG

fluorouracil

DRUG

leucovorin calcium

DRUG

oxaliplatin

Trial Locations (1)

78229-3264

San Antonio Cancer Institute, San Antonio

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

The University of Texas Health Science Center at San Antonio

OTHER

NCT00055822 - Combination Chemotherapy and Oblimersen in Treating Patients With Advanced Colorectal Cancer | Biotech Hunter | Biotech Hunter